Convalescent plasma fails to improve outcomes in severe COVID-19

Infusion of convalescent plasma is no better than placebo in terms of clinical status or mortality in patients with severe COVID-19 pneumonia, according to results of a randomised trial conducted in Argentina. “Convalescent plasma has been used for the treatment of infectious diseases for more than a century, under the assumption that passive immunisation can ...

Already a member?

Login to keep reading.

© 2021 the limbic